MRK definitive M&A: Germany's Merck to Buy U.K. Biotech Silence Therapeutics for $1.3 BillionMerck & Co., Inc.（MRK）披露确定性并购进展

RBC Capital lowers MRK target to $145RBC Capital 下调目标价 默沙东 (MRK) 至 $145

Rating Change · October 12, 2026评级变动 · 2026/10/12

Cantor Fitzgerald - Outstanding ESMO Expected raises MRK target to $145Cantor Fitzgerald - Outstanding ESMO Expected 上调目标价 默沙东 (MRK) 至 $145

Rating Change · October 8, 2026评级变动 · 2026/10/8

Scotiabank raises MRK target to $180 from $155Scotiabank 上调目标价 默沙东 (MRK)：$155 → $180

Rating Change · September 29, 2026评级变动 · 2026/9/29